MedTrace Logo

New Mexico Honey Wound Treatment Research Study

NCT01748318 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-05-10

No results posted yet for this study

Summary

In a time of emerging bacteria that are resistant to antibiotics, honey offers an alternative that has potential to reduce the heavy reliance on pharmaceutical antibiotics. We will be evaluating the effectiveness of a locally produced New Mexico Honey against the standard of care Bactrim antibiotic on Community Acquired MRSA.

Conditions

  • Community-acquired Methicillin-resistant Staphylococcus Aureus Infection

Interventions

DRUG

New Mexico Honey

Apply 15 ml of NM Honey to CA-MRSA Abscess compare to standard antibiotic treatment

DRUG

Bactrim DS

Bactrim DS

Sponsors & Collaborators

  • R. Stephen Rankin, M.D.

    lead INDIV

Principal Investigators

  • R Stephen Rankin, MD

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2018-05-31
Completion
2018-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01748318 on ClinicalTrials.gov